The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus

Journal of Rheumatology

Volumn 38, Issue 6, 2011, Pages 1012-1016

  Clowse, Megan E B ^a   Magder, Laurence S ^b   Petri, Michelle ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complement; dsDNA antibody; Pregnancy; Preterm birth; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; COMPLEMENT; DOUBLE STRANDED DNA ANTIBODY; PREDNISONE;

ADULT; ANTIBODY DETECTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HIGH RISK PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN DETERMINATION; SECOND TRIMESTER PREGNANCY; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ABORTION, SPONTANEOUS; ADULT; ANTIBODIES, ANTI-IDIOTYPIC; BIOLOGICAL MARKERS; COHORT STUDIES; COMPLEMENT C3; COMPLEMENT C4; DNA; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PREMATURE BIRTH; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STILLBIRTH;

EID: 79957829051     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100746     Document Type: Article

References (15)

1. Cortes-Hernandez J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology 2002;41:643-50. (Pubitemid 34618882)
2. Devoe LD, Loy GL. Serum complement levels and perinatal outcome in pregnancies complicated by systemic lupus erythematosus. Obstet Gynecol 1984;63:796-800. (Pubitemid 14105226)
3. Petri M. Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum Dis Clin North Am 1997;23:1-13.
4. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11. (Pubitemid 30265586)
5. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
6. Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 2005;52:514-21. (Pubitemid 40216315)
7. Gladman DD, Urowitz MB, Keystone EC. Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features. Am J Med 1979;66:210-5. (Pubitemid 9098787)
8. Clowse ME, Magder LS, Witter F, Petri M. Early risk factors for pregnancy loss in lupus. Obstet Gynecol 2006;107:293-9.
9. Ho A, Barr SG, Magder LS, Petri M. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus. Arthritis Rheum 2001;44:2350-7. (Pubitemid 32977503)
10. Buyon JP, Cronstein BN, Morris M, Tanner M, Weissmann G. Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia. Am J Med 1986;81:194-200. (Pubitemid 16018856)
11. Salmon JE, Girardi G. Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation. J Reprod Immunol 2008;77:51-6.
12. Ackerman J, Gonzalez EF, Gilbert-Barness E. Immunological studies of the placenta in maternal connective tissue disease. Pediatr Dev Pathol 1999;2:19-24. (Pubitemid 29173005)
13. Hanly JG, Gladman DD, Rose TH, Laskin CA, Urowitz MB. Lupus pregnancy. A prospective study of placental changes. Arthritis Rheum 1988;31:358-66.
14. Grennan DM, McCormick JN, Wojtacha D, Carty M, Behan W. Immunological studies of the placenta in systemic lupus erythematosus. Ann Rheum Dis 1978;37:129-34. (Pubitemid 8371840)
15. Abramowsky CR. Lupus erythematosus, the placenta, and pregnancy: a natural experiment in immunologically mediated reproductive failure. Prog Clin Biol Res 1981;70:309-20.